Ken Griffin’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-33,043
Closed -$7.27K 13024
2025
Q2
$7.27K Sell
33,043
-7,650
-19% -$1.7K ﹤0.01% 12216
2025
Q1
$9.67K Buy
+40,693
New +$12.1K ﹤0.01% 13584
2023
Q3
Sell
-22,506
Closed -$8.89K 14456
2023
Q2
$8.89K Buy
+22,506
New +$6.87K ﹤0.01% 13287
2023
Q1
Sell
-14,226
Closed -$3.56K 14860
2022
Q4
$3.56K Sell
14,226
-40,243
-74% -$12.3K ﹤0.01% 14195
2022
Q3
$23K Sell
54,469
-113
-0.2% -$67 ﹤0.01% 12019
2022
Q2
$28K Buy
54,582
+396
+0.7% +$221 ﹤0.01% 12260
2022
Q1
$33K Buy
+54,186
New +$29.6K ﹤0.01% 13050

Other funds holding DRTSW

Ken Griffin's DRTSW Position: Q3 2025 in Review

Ken Griffin sold out of Alpha Tau Medical Warrant (DRTSW) in Q3 2025, closing a stake of 33,043 shares — an estimated $7.27K sold.

Ken Griffin first reported a position in DRTSW in Q1 2022 and held it in 7 quarters. The position peaked at $33K in Q1 2022. 20 funds tracked by Wall St. Rank hold DRTSW as of Q3 2025.

  • Ken Griffin reported no remaining Alpha Tau Medical Warrant position as of Q3 2025 after selling out during the quarter.
  • Ken Griffin sold 33,043 Alpha Tau Medical Warrant shares in Q3 2025, an estimated $7.27K.
  • Ken Griffin first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 7 quarters.
  • Ken Griffin's Alpha Tau Medical Warrant position peaked at $33K in Q1 2022.
  • 20 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.